These immune responses can lead to different types of cellular interactions in the GBM tumor microenvironment, including enhanced interactions with cytotoxic T-cells through IFN signaling in females39, and enhanced immunosuppression through myeloid-derived suppressor cells through NF-kB signaling in males48. The gene discussed is NFKB1; the disease is glioblastoma.